About Arctos

• Founded: 2019

• Headquarters: Dallas, Texas

• AUM: $35bn (as of 2024)

• Strategy: GP solutions and sports franchise investing

• Track record: Prior GP stake transactions include investments in Silver Lake Partners, Lightyear Capital, and multiple professional sports franchises; firm expanded from sports-focused strategy into broader GP stakes beginning in 2020

• Leadership: Founded by Doc O'Connor and Ian Charles; O'Connor previously co-founded Northleaf Capital Partners

Arctos closed its first dedicated GP solutions fund at $6.2bn with backing from KKR. The fund represents a structural shift for Arctos, which previously executed GP stake transactions through commingled vehicles that also held sports franchise investments. KKR's participation as an anchor marks the credit manager's expansion into GP equity as a buyer, distinct from its established secondaries LP stakes business.

The close positions Arctos at the upper end of dedicated GP solutions capital — comparable to Dyal Capital's most recent $10bn close in 2021 and larger than Blackstone Strategic Partners' $8bn GP fund raised in 2022. GP stake pricing has compressed since those vintages, with multiples on management fee streams declining from 12–15x EBITDA in 2021 to 8–10x in 2024 as buyers recalibrated for higher interest rates and slower fund deployment. Arctos enters with dry powder at a moment when discounts may favor buyers, but also when seller appetite has cooled — GPs reluctant to crystallize stakes at lower valuations.

The fund's differentiation depends on whether Arctos pursues control-oriented transactions or minority stakes, and whether it underwrites primarily on existing fee streams or future fundraising assumptions. The firm's sports franchise book — where it holds stakes in teams across MLB, NBA, and European football — demonstrates comfort with long-hold, control-like positions. If that approach transfers to GP stakes, Arctos may compete more directly with Dyal and Petershill than with the flexible capital models emerging from firms like HarbourVest. The test is deployment pace: GP solutions funds raised in 2021–2022 are running at 40–50% deployed after three years, slower than historical norms. A $6.2bn vehicle needs sustained seller flow to justify the capital base.

Source: AltAssets